Encompass Health Corp director Greg D. Carmichael acquired 28 restricted stock units on October 15, 2026. The award was credited under outstanding award agreements in connection with common-stock dividend payments. His reported direct holdings following the transaction were 20,377 shares. Encompass Health paid a $0.21-per-share dividend; the closing price on the payment date was $127.77.
Encompass Health Corp director Terrance Williams acquired 28 restricted stock units on October 15, 2026, under outstanding RSU award agreements. The units were credited in connection with a common-stock dividend of $0.21 per share; the closing price on the dividend payment date was $127.77. His reported direct holdings following the transaction were 16,887 shares.
Encompass Health Corp director Nancy M. Schlichting acquired an award of 38 restricted stock units (RSUs) on October 15, 2026, in connection with a common-stock dividend payment. Her reported direct holdings after the transaction were 23,010 shares. The dividend was $0.21 per share, and the closing price on the payment date was $127.77.
Encompass Health Corp (EHC) director Joan E. Herman acquired 81 restricted stock units on October 15, 2026, under outstanding award agreements that credit additional RSUs in connection with common stock dividends. Encompass Health paid a $0.21 per-share dividend that day, when the closing price was $127.77. Her reported direct holdings following the award were 49,724 shares.
Encompass Health Corp director Edward M. Christie III reported acquiring 221 common shares on October 19, 2026, at a weighted average price of $126.63 per share through the Directors Deferred Stock Investment Plan, using quarterly fee deferrals and the October 15 dividend. He also received 11 additional RSUs on October 15 under existing award agreements in connection with the $0.21-per-share dividend.
Encompass Health Corp director Christopher R. Reidy acquired 284 common shares on October 19, 2026, at a weighted average price of $126.89 per share. The shares were purchased through the Directors Deferred Stock Investment Plan using quarterly fee deferrals and the $0.21-per-share dividend paid October 15; purchase prices ranged from $126.83 to $126.89. On October 15, Reidy also received an award of 20 restricted stock units credited in connection with the dividend.
Encompass Health director Cain A. Hayes acquired an award of 4 restricted stock units (RSUs) on October 15, 2026, associated with a common-stock dividend. Hayes's reported direct holdings after the award were 2,100 shares. Encompass Health paid a $0.21 per-share dividend that day, when the closing price was $127.77.
Encompass Health Corp director Kevin J. O'Connor acquired 18 restricted stock units on October 15, 2026, as a dividend-related award under outstanding award agreements. The company paid a common-stock dividend of $0.21 per share that day, when the closing price was $127.77. O'Connor's reported direct holdings following the transaction were 11,600 shares.
Encompass Health Corp director Leslye G. Katz received an award of 81 restricted stock units (RSUs) on October 15, 2026, under outstanding award agreements that credit RSUs in connection with common-stock dividends. Encompass Health paid a $0.21-per-share dividend that day, and the closing price was $127.77. Her reported direct holdings following the award were 49,724 shares.
Encompass Health Corp (EHC) reported that Chief Accounting Officer Andrew L. Price sold Encompass Health Common Stock in a non-derivative transaction. On 2026-08-31, he sold 5,211 shares at $120.93 per share in an open market or private transaction. Following this sale, he directly holds 69,483 shares of Encompass Health Common Stock. The filing does not indicate that the transaction was made under a Rule 10b5-1 trading plan.